We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Black Diamond Therapeutics Inc | NASDAQ:BDTX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.04 | 0.82% | 4.93 | 4.55 | 4.93 | 4.935 | 4.55 | 4.85 | 689,598 | 22:24:54 |
| | |
Per Share
|
| |
Total
|
| ||||||
Public offering price
|
| | | $ | 5.00 | | | | | $ | 75,000,000 | | |
Underwriting discounts and commissions(1)
|
| | | $ | 0.30 | | | | | $ | 4,500,000 | | |
Proceeds, before expenses, to us
|
| | | $ | 4.70 | | | | | $ | 70,500,000 | | |
| | |
Page
|
| |||
| | | | S-iii | | | |
| | | | S-iv | | | |
| | | | S-1 | | | |
| | | | S-4 | | | |
| | | | S-5 | | | |
| | | | S-7 | | | |
| | | | S-8 | | | |
| | | | S-9 | | | |
| | | | S-17 | | | |
| | | | S-21 | | | |
| | | | S-22 | | | |
| | | | S-23 | | | |
| | | | S-24 | | |
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 4 | | | |
| | | | 5 | | | |
| | | | 8 | | | |
| | | | 9 | | | |
| | | | 10 | | | |
| | | | 15 | | | |
| | | | 22 | | | |
| | | | 23 | | | |
| | | | 26 | | | |
| | | | 29 | | | |
| | | | 29 | | | |
| | | | 29 | | | |
| | | | 30 | | |
|
Public offering price per share
|
| | | | | | | | | $ | 5.00 | | |
|
Historical net tangible book value per share as of March 31, 2023
|
| | | $ | 2.69 | | | | | | | | |
|
Increase in as-adjusted net tangible book value per share attributable to this offering
|
| | | $ | 0.61 | | | | | | | | |
|
As-adjusted net tangible book value per share after this offering
|
| | | | | | | | | $ | 3.30 | | |
|
Dilution per share to new investors in this offering
|
| | | | | | | | | $ | 1.70 | | |
Underwriter
|
| |
Number
of Shares |
| |||
Piper Sandler & Co.
|
| | | | 13,125,000 | | |
Wedbush Securities Inc.
|
| | | | 1,875,000 | | |
Total
|
| | | | 15,000,000 | | |
| | |
Per
Share |
| |
Total
Without Option Exercise |
| |
Total
With Full Option Exercise |
| |||||||||
Public offering price
|
| | | $ | 5.00 | | | | | $ | 75,000,000 | | | | | $ | 86,250,000 | | |
Underwriting discount and commissions
|
| | | $ | 0.30 | | | | | $ | 4,500,000 | | | | | $ | 5,175,000 | | |
Proceeds, before expenses, to us
|
| | | $ | 4.70 | | | | | $ | 70,500,000 | | | | | $ | 81,075,000 | | |
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 4 | | | |
| | | | 5 | | | |
| | | | 8 | | | |
| | | | 9 | | | |
| | | | 10 | | | |
| | | | 15 | | | |
| | | | 22 | | | |
| | | | 23 | | | |
| | | | 26 | | | |
| | | | 29 | | | |
| | | | 29 | | | |
| | | | 29 | | | |
| | | | 30 | | |
1 Year Black Diamond Therapeutics Chart |
1 Month Black Diamond Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions